Evaluation of Multiple Tissue Levels Frequently Upstages Patients With Clinically Localized Thin Primary Cutaneous Melanoma.

Autor: Jackett LA; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Gullifer JP; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital & NSW Health Pathology, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Publikováno v: Journal of cutaneous pathology [J Cutan Pathol] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.

Merkel cell carcinoma: an unusual case with SOX10 nuclear staining.

Autor: Wong AS; Department of Anatomical Pathology, Austin Hospital, Heidelberg Vic, Australia. Electronic address: anders.sm.wong@gmail.com., du Plessis JJ; Department of Anatomical Pathology, Austin Hospital, Heidelberg Vic, Australia., Jackett LA; Department of Anatomical Pathology, Austin Hospital, Heidelberg Vic, Australia.

Publikováno v: Pathology [Pathology] 2023 Aug; Vol. 55 (5), pp. 718-721. Date of Electronic Publication: 2023 Feb 23.

Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment.

Autor: Star P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Jackett LA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Cheung K; Anatomical Pathology, Skin & Cancer Foundation Australia/Douglass Hanly Moir Pathology, Darlinghurst, New South Wales, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Ho G; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Smith A; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Martin LK; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of New South Wales, Sydney, New South Wales, Australia.

Publikováno v: Dermatologic therapy [Dermatol Ther] 2022 Jun; Vol. 35 (6), pp. e15472. Date of Electronic Publication: 2022 Apr 05.

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.

Autor: Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au., Atkinson V; Princess Alexandra Hospital & Greenslopes Private Hospital, Brisbane, Qld, Australia; Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Qld, Australia; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia., Gyorki DE; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia., Lambie D; Anatomical Pathology, Princess Alexandra Hospital, Pathology Queensland, Brisbane, Qld, Australia; University of Queensland Diamantina Institute, Brisbane, Qld, Australia., O'Toole S; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia., Amanuel B; School of Medical and Health Sciences, Edith Cowan University, WA, Australia; PathWest Laboratory Medicine WA, Nedlands, WA, Australia., Angel CM; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia., Button-Sloan AE; Australia Melanoma Consumer Alliance, Melbourne, Vic, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Colebatch AJ; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Daneshvar D; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Pathology West, Tissue Pathology & Diagnostic Oncology, ICPMR-Westmead, Sydney, NSW, Australia., Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Sydney, NSW, Australia., Dawson T; Melanoma & Skin Cancer Advocacy Network, Melbourne, Vic, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Foster-Smith E; SA Pathology, Royal Adelaide Hospital, Adelaide, SA, Australia., Fox SB; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; University of Melbourne, Melbourne, Vic, Australia., Gill AJ; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, NSW, Australia., Gupta R; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Henderson MA; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia., Hong AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia., Howle JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia., Jackett LA; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Austin Pathology, Melbourne, Vic, Australia., James C; Clinpath Pathology, Mile End, Adelaide, SA, Australia., Lee CS; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Campbelltown, Sydney, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, Sydney, NSW, Australia; Liverpool Hospital, Liverpool, Sydney, NSW, Australia; South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia., Lochhead A; Southern.IML Pathology, Coniston, NSW, Australia; The Wollongong Hospital, Wollongong, NSW, Australia; University of Wollongong, Wollongong, NSW, Australia., Loh D; ACT Pathology, Canberra Hospital, Canberra, ACT, Australia., McArthur GA; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia., McLean CA; Anatomical Pathology Department, Alfred Hospital, Melbourne, Vic, Australia; Department of Medicine Central Clinical School, Monash University, Melbourne, Vic, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., O'Brien BH; Sullivan Nicolaides Pathology, Brisbane, Qld, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Potter AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Prakash S; Melbourne Pathology (Sonic Healthcare), Melbourne, Vic, Australia., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Read RL; Calvary Health Care, Canberra, ACT, Australia; College of Health and Medicine, Australian National University, Canberra, ACT, Australia., Rtshiladze MA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Smithers BM; Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Qld, Australia; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Tucker P; Hobart Pathology, Hobart, Tas, Australia., Varey AHR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia., Vilain RE; NSW Health Pathology, Sydney, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; John Hunter Hospital, Newcastle, NSW, Australia., Wood BA; PathWest Laboratory Medicine WA, Nedlands, WA, Australia; The University of Western Australia, Perth, WA, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia.

Publikováno v: Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 6-19. Date of Electronic Publication: 2021 Dec 20.

Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy.

Autor: Jackett LA; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., Colebatch AJ; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., Rawson RV; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., Ferguson PM; Royal Prince Alfred Hospital.; Melanoma Institute Australia., Thompson JF; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., McCarthy SW; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Royal Prince Alfred Hospital.; Melanoma Institute Australia.; Central Clinical School, The University of Sydney, Sydney, NSW, Australia.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2020 Mar; Vol. 44 (3), pp. 357-367.